Oral GLP-1 drugs are typically taken once a day, with some patients noticing results within a few weeks of starting the medication
Particular attention is needed for insulin and sulfonylureas (hypoglycemia risk), oral contraceptives (reduced absorption), thyroid medications (altered absorption timing), and blood thinners (variable absorption)
gordonii by increasing the activity of S
Many people are intrigued by the idea of using smaller doses to ease side effects or maintain results after weight loss
Patients have reported decreased interest in alcohol and nicotine when taking GLP-1s, and observational studies have shown an association between treatment with GLP-1 medication and lower risk of alcohol and cannabis use disorders, opioid overdose, and alcohol-related hospitalization
As expected, and consistent with a reduced interaction of the amidated C-terminal tyrosine with the CTR ECD, CagriP37Y presented a lower potency than Cagri in cells expressing CTR alone (Supplementary Fig